Jose A. Moro
Research Subjects
Research Interests
Jose A. Moro has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Luis Martínez-Dolz
Cardiology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain
15 shared publications L. Almenar
Heart Failure and Transplant Unit, Cardiology, Internal Medicine, La Fe University Hospital, Valencia, Spain
12 shared publicationsA. Salvador
Heart Failure and Transplant Unit, Cardiology, Internal Medicine, La Fe University Hospital, Valencia, Spain
11 shared publications- Ignacio Sánchez-Lázaro
Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain; Department of Cardiology, La Fe University and Polytechnic Hospital, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain
10 shared publications Antonio Salvador
7 shared publicationsLuis Almenar
7 shared publications
Latest Publications
- 1 March 2009
- Published by Elsevier in Sleep Medicine
- Vol. 10 (3) , 344-352
Hypertension and sleep apnea–hypopnea syndrome: changes in echocardiographic abnormalities depending on the presence of hypertension and treatment with CPAP
- 1 March 2009
- Published by Elsevier in Sleep Medicine
- Vol. 10 (3) , 344-352
Hypertension and sleep apnea–hypopnea syndrome: changes in echocardiographic abnormalities depending on the presence of hypertension and treatment with CPAP
- 27 February 2009
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (4) , 538-541
Progression of Renal Dysfunction in Cardiac Transplantation After the Introduction of Everolimus in the Immunosuppressive Regime
The aim of this study was to analyze, in heart transplant patients, if renal function improvement after cyclosporine replacement by everolimus persists at the middle term and its predictors. We studied prospectively 56 patients in whom conversion was consecutively made. Forty-five patients completed the follow-up period. Significant improvement was observed at 6 and 12 months in plasma creatinine levels (1.92±0.7 vs. 1.67±0.6 and 1.69±0.6 mg/dL; P=0.047) and glomerular filtration rate (43.9±17 vs. 52.5±23 and 51.3±22.3 mL/min; P=0.004). Glomerular filtration rate increased in 32 patients (71%). Baseline characteristics comparison showed a lower percentage of patients with smoking history and new onset diabetes in responders group, but only previous smoking was shown as independent factor (Exp B: 0.083; 95% confidence interval: 0.010–0.793; P=0.024). No differences regarding age, gender, body mass index, disease leading to transplantation, time between transplantation and replacement, cardiovascular risk factors, lipid levels, and hematologic parameters were found.
- 27 February 2009
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (4) , 538-541
Progression of Renal Dysfunction in Cardiac Transplantation After the Introduction of Everolimus in the Immunosuppressive Regime
The aim of this study was to analyze, in heart transplant patients, if renal function improvement after cyclosporine replacement by everolimus persists at the middle term and its predictors. We studied prospectively 56 patients in whom conversion was consecutively made. Forty-five patients completed the follow-up period. Significant improvement was observed at 6 and 12 months in plasma creatinine levels (1.92±0.7 vs. 1.67±0.6 and 1.69±0.6 mg/dL; P=0.047) and glomerular filtration rate (43.9±17 vs. 52.5±23 and 51.3±22.3 mL/min; P=0.004). Glomerular filtration rate increased in 32 patients (71%). Baseline characteristics comparison showed a lower percentage of patients with smoking history and new onset diabetes in responders group, but only previous smoking was shown as independent factor (Exp B: 0.083; 95% confidence interval: 0.010–0.793; P=0.024). No differences regarding age, gender, body mass index, disease leading to transplantation, time between transplantation and replacement, cardiovascular risk factors, lipid levels, and hematologic parameters were found.
- 17 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3063-3064
Utility of Oral Valganciclovir for Cytomegalovirus Prophylaxis: Does It Improve Treatment Compliance?
- 17 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3063-3064
Utility of Oral Valganciclovir for Cytomegalovirus Prophylaxis: Does It Improve Treatment Compliance?
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3034-3036
Tolerance Profile of the Proliferation Signal Inhibitors Everolimus and Sirolimus in Heart Transplantation
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3034-3036
Tolerance Profile of the Proliferation Signal Inhibitors Everolimus and Sirolimus in Heart Transplantation
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3039-3040
Support Program for Heart Transplant Patients: Initial Experience
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 3039-3040
Support Program for Heart Transplant Patients: Initial Experience
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 2906-2908
Randomized Prospective Study of the Evolution of Renal Function Depending on the Anticalcineurin Used
- 1 November 2008
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (9) , 2906-2908
Randomized Prospective Study of the Evolution of Renal Function Depending on the Anticalcineurin Used
- 1 June 2008
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 27 (6) , 689-691
Heart Transplantation in a Patient With Systemic Mastocytosis
- 1 June 2008
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 27 (6) , 689-691
Heart Transplantation in a Patient With Systemic Mastocytosis
- 1 January 2008
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 61 (1) , 49-57
Analysis of Echocardiographic Alterations Observed in Sleep Apnea–Hypopnea Syndrome and How They Are Influenced by Hypertension
- 1 January 2008
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 61 (1) , 49-57
Analysis of Echocardiographic Alterations Observed in Sleep Apnea–Hypopnea Syndrome and How They Are Influenced by Hypertension
- 1 January 2008
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 44 (8) , 418-423
[Silent heart disease in patients with sleep apnea-hypopnea syndrome: usefulness of the myocardial performance index].
- 1 January 2008
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 44 (8) , 418-423
[Silent heart disease in patients with sleep apnea-hypopnea syndrome: usefulness of the myocardial performance index].
- 20 September 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (7) , 2135-2137
mTOR Inhibitors: Do They Help Preserve Renal Function?
- 20 September 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (7) , 2135-2137
mTOR Inhibitors: Do They Help Preserve Renal Function?